US Stock MarketDetailed Quotes

Lexeo Therapeutics (LXEO)

Watchlist
  • 5.850
  • -0.160-2.66%
Close Apr 24 15:59 ET
  • 5.850
  • 0.0000.00%
Post 20:01 ET
433.41MMarket Cap-3.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexeo Therapeutics (LXEO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
3.30%109.26M
-15.58%23.12M
-31.37%21.65M
30.31%30.69M
45.14%33.81M
54.37%105.77M
82.86%27.38M
55.59%31.54M
68.52%23.55M
20.74%23.29M
Selling and administrative expenses
43.52%45.46M
-23.40%6.91M
-26.69%5.95M
128.43%15.97M
120.35%16.63M
105.91%31.68M
33.29%9.02M
168.25%8.12M
155.20%6.99M
164.69%7.55M
-General and administrative expense
43.52%45.46M
-23.40%6.91M
-26.69%5.95M
128.43%15.97M
120.35%16.63M
105.91%31.68M
33.29%9.02M
168.25%8.12M
155.20%6.99M
164.69%7.55M
Research and development costs
-13.89%63.8M
-11.74%16.21M
-32.99%15.7M
-11.11%14.72M
9.08%17.17M
39.45%74.09M
123.70%18.37M
35.82%23.42M
47.38%16.56M
-4.23%15.74M
Operating profit
-3.30%-109.26M
15.58%-23.12M
31.37%-21.65M
-30.31%-30.69M
-45.14%-33.81M
-54.37%-105.77M
-82.86%-27.38M
-55.59%-31.54M
-68.52%-23.55M
-20.74%-23.29M
Net non-operating interest income expense
-20.40%5.92M
50.07%2.19M
-33.20%1.37M
-47.73%1.21M
-28.56%1.15M
179.56%7.44M
38.59%1.46M
371.79%2.06M
330.73%2.31M
153.38%1.61M
Non-operating interest income
-19.12%6.13M
48.72%2.21M
-30.40%1.46M
-46.00%1.27M
-27.74%1.19M
164.35%7.58M
35.03%1.49M
328.69%2.09M
297.97%2.35M
140.32%1.65M
Non-operating interest expense
50.36%206K
-16.67%25K
134.29%82K
68.57%59K
8.11%40K
-33.17%137K
-40.00%30K
-32.69%35K
-33.96%35K
-26.00%37K
Other net income (expense)
37,566.67%3.37M
9K
-200.00%-9K
337,700.00%3.38M
20.00%-4K
98.34%-9K
0
98.89%-3K
66.67%-1K
-25.00%-5K
Gain on sale of security
--3.39M
--0
----
--3.39M
----
----
----
----
----
----
Other non- operating income (expenses)
-100.00%-18K
--9K
-200.00%-9K
-1,300.00%-14K
20.00%-4K
30.77%-9K
--0
-400.00%-3K
66.67%-1K
-25.00%-5K
Income before tax
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
Net income continuous Operations
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
Minority interest income
Net income attributable to the parent company
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
Basic earnings per share
39.81%-1.86
65.38%-0.27
62.92%-0.33
6.25%-0.6
-28.57%-0.99
75.08%-3.09
-46.50%-0.78
-11.40%-0.89
-19.85%-0.64
-3.88%-0.77
Diluted earnings per share
39.81%-1.86
65.38%-0.27
62.92%-0.33
6.25%-0.6
-28.57%-0.99
75.08%-3.09
-46.50%-0.78
-11.40%-0.89
-19.85%-0.64
-3.88%-0.77
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 3.30%109.26M-15.58%23.12M-31.37%21.65M30.31%30.69M45.14%33.81M54.37%105.77M82.86%27.38M55.59%31.54M68.52%23.55M20.74%23.29M
Selling and administrative expenses 43.52%45.46M-23.40%6.91M-26.69%5.95M128.43%15.97M120.35%16.63M105.91%31.68M33.29%9.02M168.25%8.12M155.20%6.99M164.69%7.55M
-General and administrative expense 43.52%45.46M-23.40%6.91M-26.69%5.95M128.43%15.97M120.35%16.63M105.91%31.68M33.29%9.02M168.25%8.12M155.20%6.99M164.69%7.55M
Research and development costs -13.89%63.8M-11.74%16.21M-32.99%15.7M-11.11%14.72M9.08%17.17M39.45%74.09M123.70%18.37M35.82%23.42M47.38%16.56M-4.23%15.74M
Operating profit -3.30%-109.26M15.58%-23.12M31.37%-21.65M-30.31%-30.69M-45.14%-33.81M-54.37%-105.77M-82.86%-27.38M-55.59%-31.54M-68.52%-23.55M-20.74%-23.29M
Net non-operating interest income expense -20.40%5.92M50.07%2.19M-33.20%1.37M-47.73%1.21M-28.56%1.15M179.56%7.44M38.59%1.46M371.79%2.06M330.73%2.31M153.38%1.61M
Non-operating interest income -19.12%6.13M48.72%2.21M-30.40%1.46M-46.00%1.27M-27.74%1.19M164.35%7.58M35.03%1.49M328.69%2.09M297.97%2.35M140.32%1.65M
Non-operating interest expense 50.36%206K-16.67%25K134.29%82K68.57%59K8.11%40K-33.17%137K-40.00%30K-32.69%35K-33.96%35K-26.00%37K
Other net income (expense) 37,566.67%3.37M9K-200.00%-9K337,700.00%3.38M20.00%-4K98.34%-9K098.89%-3K66.67%-1K-25.00%-5K
Gain on sale of security --3.39M--0------3.39M------------------------
Other non- operating income (expenses) -100.00%-18K--9K-200.00%-9K-1,300.00%-14K20.00%-4K30.77%-9K--0-400.00%-3K66.67%-1K-25.00%-5K
Income before tax -1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M
Income tax 0000000000
Net income -1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M
Net income continuous Operations -1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M
Minority interest income
Net income attributable to the parent company -1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M
Basic earnings per share 39.81%-1.8665.38%-0.2762.92%-0.336.25%-0.6-28.57%-0.9975.08%-3.09-46.50%-0.78-11.40%-0.89-19.85%-0.64-3.88%-0.77
Diluted earnings per share 39.81%-1.8665.38%-0.2762.92%-0.336.25%-0.6-28.57%-0.9975.08%-3.09-46.50%-0.78-11.40%-0.89-19.85%-0.64-3.88%-0.77
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -